Yehenew M. Agazie

Biochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Design and synthesis of improved active-site SHP2 inhibitors with anti-breast cancer cell effects”.

Design and synthesis of improved active-site SHP2 inhibitors with anti-breast cancer cell effects

European Journal of Medicinal Chemistry(2022)10.1016/j.ejmech.2022.115017

N/A

0DataRank · unranked

10 citations

Roxy Nicoletti, James Mersch, Yehenew M. Agazie, Dhanaji M. Lade

Gram-scale synthesis of the thiazolidinedione-based mitoNEET ligand NL-1 using a Hantzsch ester reduction

Tetrahedron Letters(2025)10.1016/j.tetlet.2025.155863

N/A

0DataRank · unranked

1 citations

Yehenew M. Agazie, Michael A. Menze, Mary E. Konkle, Jason D. Huber, Werner J. Geldenhuys +1 more

Development of a more penetrating HER2-positive Breast Cancer Tumor Model and Testing Efficacy of SHP2 Targeting with an Active-Site Inhibitor

Research Square(2025)10.21203/rs.3.rs-8196938/v1

N/A

0DataRank · unranked

0 citations

James Mersch, Dhanaji M. Lade, Paul R. Lockman, Yehenew M. Agazie